Phenylephrine
Phenylephrine is a medication used as a decongestant for uncomplicated nasal congestion, used to dilate the pupil, used to increase blood pressure (given intravenously in cases of low blood pressure), and used to relieve hemorrhoids. It can be taken by mouth, as a nasal spray, given by injection into a vein or muscle, or applied to the skin.
Clinical data | |
---|---|
Pronunciation | /ˌfɛnəlˈɛfriːn, fiː-, -ɪn/ |
Trade names | Neo-synephrine, others |
AHFS/Drugs.com | Monograph |
License data |
|
Routes of administration | By mouth, in the nose, on the eye, intravenous, intramuscular |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 38% through GI tract |
Protein binding | 95% |
Metabolism | Liver (oxidative deamination) |
Onset of action | Very rapid (IV); within 20 min (by mouth) |
Elimination half-life | 2.1–3.4 h |
Duration of action | Up to 20 min (IV); 4 hrs (by mouth) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.386 |
Chemical and physical data | |
Formula | C9H13NO2 |
Molar mass | 167.208 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Common side effects when taken by mouth or injected include nausea, vomiting, headache, and anxiety. Use on hemorrhoids is generally well tolerated. Severe side effects may include a slow heart rate, intestinal ischemia, chest pain, kidney failure, and tissue death at the site of injection. It is unclear whether its use during pregnancy and breastfeeding is safe. Phenylephrine is a selective α1-adrenergic receptor agonist with minimal to no β-adrenergic receptor agonist activity. It causes constriction of both arteries and veins.
Phenylephrine was patented in 1933 and came into medical use in 1938. It is available as a generic medication. Unlike pseudoephedrine, abuse of phenylephrine is very uncommon. Its effectiveness as a nasal decongestant has been questioned. In 2023, a Food and Drug Administration panel concluded that the drug was ineffective as a nasal decongestant when taken orally.